COMPARATIVE EFFECTIVENESS OF DENOSUMAB VERSUS ORAL BISPHOSPHONATES AMONG POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS IN THE US MEDICARE PROGRAM

被引:0
|
作者
Curtis, J. [1 ]
机构
[1] Univ Alabama Birmingham, Div Clin Immunol & Rheumatol, Birmingham, AL USA
关键词
D O I
暂无
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
SY6
引用
收藏
页码:S580 / S580
页数:1
相关论文
共 50 条
  • [1] Comparative Effectiveness of Denosumab versus Bisphosphonates among Treatment-Experienced Postmenopausal Women with Osteoporosis in the US Medicare Program
    Curtis, Jeffrey
    Arora, Tarun
    Liu, Ye
    Lin, Tzu-Chieh
    Spangler, Leslie
    Brunetti, Vanessa
    Stad, Robert
    McDermott, Michele
    Bradbury, Brian
    Kim, Min
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 64 - 64
  • [2] COMPARATIVE EFFECTIVENESS OF DENOSUMAB VERSUS BISPHOSPHONATES AMONG TREATMENT-EXPERIENCED POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS IN THE US MEDICARE PROGRAM
    Curtis, J. R.
    Aurora, T.
    Liu, Y.
    Lin, T. C.
    Spangler, L.
    Brunetti, V. C.
    Stad, R. K.
    Mcdermott, M.
    Bradbury, B. D.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 : S6 - S6
  • [3] Comparative effectiveness of denosumab versus bisphosphonates among treatment-experienced postmenopausal women with osteoporosis in the US Medicare program
    Curtis, Jeffrey R.
    Arora, Tarun
    Liu, Ye
    Brunetti, Vanessa
    Lin, Jay
    Stad, Robert
    Spangler, Leslie
    McDermott, Michele
    Bradbury, Brian
    Kim, Min
    CURRENT MEDICAL RESEARCH AND OPINION, 2024, 40 : S29 - S29
  • [4] COMPARATIVE EFFECTIVENESS OF DENOSUMAB VERSUS ALENDRONATE AMONG POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS IN THE US MEDICARE PROGRAM
    Curtis, J. R.
    Arora, T.
    Liu, Y.
    Lin, T. -C.
    Spangler, L.
    Brunetti, V. C.
    Stad, R. K.
    Mcdermott, M.
    Bradbury, B. D.
    Kim, M.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S55 - S56
  • [5] Comparative Effectiveness of Denosumab versus Alendronate Among Postmenopausal Women with Osteoporosis in the US Medicare Program
    Curtis, Jeffrey
    Arora, Tarun
    Liu, Ye
    Lin, Tzu-Chieh
    Spangler, Leslie
    Brunetti, Vanessa C.
    Stad, Robert K.
    McDermott, Michele
    Bradbury, Brian D.
    Kim, Min
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 3979 - 3981
  • [6] Comparative effectiveness of denosumab versus zoledronic acid among postmenopausal women with osteoporosis in the US Medicare program
    Curtis, Jeffrey R.
    Arora, Tarun
    Liu, Ye
    Brunetti, Vanessa
    Lin, Jay
    Stad, Robert
    McDermott, Michele
    Spangler, Leslie
    Bradbury, Brian
    Kim, Min
    CURRENT MEDICAL RESEARCH AND OPINION, 2024, 40 : S29 - S30
  • [7] Comparative Effectiveness of Denosumab versus Zoledronic Acid among Postmenopausal Women with Osteoporosis in the US Medicare Program
    Curtis, Jeffrey
    Arora, Tarun
    Liu, Ye
    Lin, Tzu-Chieh
    Spangler, Leslie
    Brunetti, Vanessa
    Stad, Robert
    McDermott, Michele
    Bradbury, Brian
    Kim, Min
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 2 - 2
  • [8] Comparative Effectiveness of Denosumab versus Zoledronic Acid Among Postmenopausal Women with Osteoporosis in the US Medicare Program
    Curtis, Jeffrey R.
    Arora, Tarun
    Liu, Ye
    Brunetti, Vanessa C.
    Lin, Tzu-Chieh
    Spangler, Leslie
    Stad, Robert K.
    McDermott, Michele
    Bradbury, Brian D.
    Kim, Min
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 5021 - 5022
  • [9] COMPARATIVE EFFECTIVENESS OF DENOSUMAB VERSUS ZOLEDRONIC ACID AMONG POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS IN THE US MEDICARE PROGRAM
    Curtis, J. R.
    Arora, T.
    Liu, Y.
    Lin, T-C
    Spangler, L.
    Brunetti, V. C.
    Stad, R. K.
    Mcdermott, M.
    Bradbury, B. D.
    Kim, M.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 : S583 - S583
  • [10] Cost effectiveness of denosumab versus oral bisphosphonates for postmenopausal osteoporosis in the US
    Parthan A.
    Kruse M.
    Yurgin N.
    Huang J.
    Viswanathan H.N.
    Taylor D.
    Applied Health Economics and Health Policy, 2013, 11 (5) : 485 - 497